idoxuridine has been researched along with Pancreatic Neoplasms in 4 studies
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "One patient with recurrent ovarian cancer who received 16 courses of therapy experienced complete resolution of her ascites, near normalization of CA-125 levels, and improved quality of life; two patients with high-risk tumors receiving "adjuvant" therapy are disease-free at 3 and 6 years after treatment; other patients experienced transient clearing of ascites." | 2.69 | Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. ( Akman, S; Carroll, M; Chow, W; Coluzzi, P; Doroshow, JH; Hamasaki, V; Klevecz, R; Leong, L; Longmate, J; Margolin, K; McGonigle, K; Morgan, RJ; Newman, EM; Paz, B; Raschko, J; Shibata, S; Somlo, G; Tetef, M; Vasilev, S; Wagman, L; Yen, Y, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rebischung, C | 1 |
| Hoffmann, D | 1 |
| Stefani, L | 1 |
| Desruet, MD | 1 |
| Wang, K | 1 |
| Adelstein, SJ | 1 |
| Artignan, X | 1 |
| Vincent, F | 1 |
| Gauchez, AS | 1 |
| Zhang, H | 1 |
| Fagret, D | 1 |
| Vuillez, J | 1 |
| Kassis, AI | 1 |
| Balosso, J | 1 |
| CLIFTON, KH | 1 |
| SZYBALSKI, W | 1 |
| HEIDELBERGER, C | 1 |
| GOLLIN, FF | 1 |
| ANSFIELD, FJ | 1 |
| VERMUND, H | 1 |
| Robertson, JM | 1 |
| Shewach, DS | 1 |
| Lawrence, TS | 1 |
| Morgan, RJ | 1 |
| Newman, EM | 1 |
| Doroshow, JH | 1 |
| McGonigle, K | 1 |
| Margolin, K | 1 |
| Raschko, J | 1 |
| Chow, W | 1 |
| Somlo, G | 1 |
| Leong, L | 1 |
| Tetef, M | 1 |
| Shibata, S | 1 |
| Hamasaki, V | 1 |
| Carroll, M | 1 |
| Vasilev, S | 1 |
| Akman, S | 1 |
| Coluzzi, P | 1 |
| Wagman, L | 1 |
| Longmate, J | 1 |
| Paz, B | 1 |
| Yen, Y | 1 |
| Klevecz, R | 1 |
1 review available for idoxuridine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma.
Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Combined Modality Therapy; Deoxycytidine; Floxur | 1996 |
1 trial available for idoxuridine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; CA-125 Antigen; DNA, Neoplasm; Drug Adminis | 1998 |
2 other studies available for idoxuridine and Pancreatic Neoplasms
| Article | Year |
|---|---|
First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
Topics: Adult; Antibiotics, Antineoplastic; Antigens, Tumor-Associated, Carbohydrate; Brain Neoplasms; Combi | 2008 |
INCORPORATION OF I-125-LABELED IODODEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF MURINE AND HUMAN TISSUES FOLLOWING THERAPEUTIC DOSES.
Topics: Adenocarcinoma; Animals; DNA; DNA, Neoplasm; Floxuridine; Geriatrics; Idoxuridine; Intestine, Small; | 1963 |